Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Domestically Developed Universal Immune Priming Therapy Launches Clinical Program - Targeting "Cold Tumors" Unresponsive to PD-1 Treatments
WHO's Tedros says Ebola response must be scaled up to tackle Congo outbreak
Updated COVID-19 vaccines are coming this fall. Will insurance cover them?
Jim Cramer Explains Why Heavily Shorted Moderna (MRNA) Has Room to Run
Top Value Stocks To Follow Today - September 2nd - Stock Observer
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
US Stock Market Today: S&P 500 Futures Slip As Rising Yields Pressure Equities
Brookline Capital Markets Forecasts Moderna Q3 Earnings - Stock Observer
Did Merck's (MRK) First Positive Phase 3 Individualized mRNA Cancer Trial Just Redefine Its Moat?
Traders Buy Large Volume of Call Options on Moderna (NASDAQ:MRNA) - Markets Daily
Stock Market Today, Sept. 1: Stocks Slide and Oil Surges Amid U.S.-Iran Tension
Moderna Target of Unusually Large Options Trading (NASDAQ:MRNA) - Stock Observer
Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III
Moderna (NASDAQ:MRNA) Trading 3.6% Higher - Here's What Happened
GSK hopes to take on Moderna as it moves mRNA flu vaccine to Phase III trial
S&P 500 biggest August 2026 winners: Moderna, software stocks
Moderna FY2029 EPS Lowered by Brookline Capital Markets
Van ECK Associates Corp Trims Stake in Moderna, Inc. $MRNA
Moderna Stock More Than Doubled in August. Is the Stock a Buy, a Hold, or a Sell?
Moderna (MRNA) Soars 156% in August - Here's What Propelled The Rally
Wellington Management Group LLP Boosts Stock Holdings in Moderna, Inc. $MRNA - Daily Political
Financings: Ausperbio's $120M series C; Moderna's $2.6B private placement | BioWorld
New COVID-19 vaccines approved for 2026-27 to combat latest active viruses | News & Features | ArcaMax Publishing
Inside the scramble to regulate AI
5 deals that fueled African music's global takeover
Best Biotech Stocks Worth Watching - August 31st - Daily Political
Alyeska Investment Group L.P. Trims Stake in Moderna, Inc. $MRNA
Moderna, Inc. (NASDAQ:MRNA) Given Average Rating of "Hold" by Brokerages
Jim Cramer Called Moderna Inc. (NASDAQ:MRNA) & Merck's Trial Results Encouraging
The sudden unraveling of Wall Street's momentum trade
Best Value Stocks To Watch Now - August 30th - Markets Daily
Is It Too Late to Buy Moderna Stock After Its 127% Surge?
Man Group plc Purchases New Shares in Moderna, Inc. $MRNA
VOO vs. RSP: If AI Stocks Get Too Concentrated, Here's Which One I'd Choose
Healthcare's Best Week Since June Traces Back to a Single Moderna and Merck Cancer Trial
What Do Moderna (MRNA) FDA Vaccine Approvals Mean For Its Respiratory Push?
'This Breakup Saved You Far More Than Moderna Ever Could': Orman to Woman Dumped After 180% Spike
Ieq Capital LLC Buys New Stake in Moderna, Inc. $MRNA - Zolmax
Centaurus Financial Inc. Takes Position in Moderna, Inc. $MRNA - Markets Daily
9,448 Shares in Moderna, Inc. $MRNA Purchased by Ieq Capital LLC
Best Biotech Stocks To Research - August 29th - Daily Political
Moderna (NASDAQ:MRNA) Shares Gap Down - Should You Sell? - Daily Political
moderna and merck's breakthrough mRNA cancer vaccine success | The Straits Times
Moderna (MRNA) Plans $2B of Zero-Coupon Convertible Debt. Is the Capped Call Enough to Control Dilution?
FDA Approves 3 New COVID-19 Vaccines
Jim Cramer Says Hold on to Moderna (MRNA) After Phase 3 Cancer Trial
Moderna (MRNA) & Merck (MRK): What's Happening With These Two Stocks? - Insider Monkey
Updated COVID shots are approved. Getting one may not be simple
Moderna (MRNA), Merck (MRK) Cancer Vaccine Wins in Late-Stage Trial
Moderna matches record 175% capped-call strike on US$2.6bn CB | IFR
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax - Update | Morningstar
Moderna Stock Falls 6% On Announcement Of $2.6 Bln Private Offering Of Convertible Senior Notes
BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat
FDA approves updated COVID vaccines targeting XFG 'Stratus' variant
简报聊天:多莉·帕顿如何在科学领域留下自己的印记
Moderna (NASDAQ:MRNA) Sees Strong Trading Volume Following Analyst Upgrade
BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast
Moderna (MRNA) Stock Earns Another Upgrade on Intismeran Success
Moderna, Inc. (MRNA) Stock: Slide as Company Upsizes Debt Offering to $2.6 Billion
Moderna (MRNA) Stock Drops 4.6% Despite Groundbreaking Cancer Vaccine Breakthrough
Moderna (NASDAQ:MRNA) Sees Strong Trading Volume on Analyst Upgrade - Stock Observer
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Yahoo News Singapore
Best Healthcare Stocks To Follow Now - August 28th - Daily Political
OMERS ADMINISTRATION Corp Purchases New Stake in Moderna, Inc. $MRNA
Best Biotech Stocks To Research - August 28th - Daily Political
Promising Healthcare Stocks To Follow Today - August 25th - Stock Observer
US FDA approves new Covid-19 vaccines ahead of 2026-27 season; here's who can get them
FDA approves updated Covid-19 vaccines
Tempus AI (TEM) Jumped on Moderna's Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech | Morningstar
BioNTech (BNTX) Rallied on Moderna's Win. Does a Competitor's Success Validate its Oncology Pipeline?
Cathie Wood sells $4 million of surging AI stock
Biotech Stocks To Watch Today - August 27th - Markets Daily
Moderna (NASDAQ:MRNA) Shares Gap Down - Here's What Happened - Markets Daily
Moderna (MRNA) Stock: Slips After Announcing $2 Billion Debt Plan to Fund Growth Strategy
Top Healthcare Stocks To Watch Now - August 27th - Stock Observer
Moderna Capitalizes on Stock Jump With $2 Billion Offering (1)
Moderna raises $2 billion in convertible notes for cancer vaccine
Moderna (NASDAQ:MRNA) Shares Gap Down - Here's What Happened - Stock Observer
Parallax Volatility Advisers L.P. Invests $2.76 Million in Moderna, Inc. $MRNA
Promising Value Stocks To Consider - August 24th - Markets Daily
11,211 Shares in Moderna, Inc. $MRNA Bought by Quantbot Technologies LP
3,753 Shares in Moderna, Inc. $MRNA Acquired by Evolve Private Wealth LLC - Markets Daily
12,894 Shares in Moderna, Inc. $MRNA Bought by Ausdal Financial Partners Inc.
EFG International AG Makes New Investment in Moderna, Inc. $MRNA - Daily Political
3,753 Shares in Moderna, Inc. $MRNA Purchased by Evolve Private Wealth LLC - Stock Observer
